More and more, care is moving into the home with new tools and technologies that can monitor patients, but this raises the question of how to handle this new data, said John D. Halamka, MD, MS, of Beth Israel Deaconess Health System.
More and more, care is moving into the home with new tools and technologies that can monitor patients, but this raises the question of how to handle this new data, said John D. Halamka, MD, MS, of Beth Israel Deaconess Health System.
Transcript
In the next 1 to 2 years, what trends do you expect to see in digital health?
So, I never forecast much more than, say, 6 quarters, because who knows? We'll have flying cars and Facebook implants in several years—or not. But in digital health, we're seeing a few trends, such as movement of care from the outpatient or inpatient setting to the home. And having the tools and technologies to monitor patients in the home. We’re seeing the movement of data from electronic health records that are stored in siloes to the cloud, and more and more data for analytics and machine learning. We’re seeing the notion of care at a distance in telemedicine/telecare not necessarily requiring a visit to a specific location.
So, that kind of combination of, I’ll gather more data about you from you, and help you be healthy in your home, as opposed to wait until you’re sick, is probably the most important trend of the next 6 quarters.
With technologies to monitor patients moving into the home, where is that data being collected going or how is it being utilized? Do patients know?
So, you ask this brilliant question about what do we do with all this new data coming from patients. I’ll tell you, it’s very early. Much of the data today goes into a patient portal or a patient app where it’s managed by the patient. Maybe there are some tools for the patient, but it may not be reviewed by a provider or provider team.
And we are asking the following question: era of meaningful use, when you have 11 minutes to see the patient, be empathetic, make eye contact, can you really take the time to review all the patient-generated data? Maybe not the raw data, but maybe its interpretation.
So, we’re asking: what are the tools and technologies to incorporate in provider workflow that will turn that data into wisdom and make it actionable by the provider team? That’s the work of the next year, because it’s very early days.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More